Goh V - Search Results

1

Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment.

Cook GJ, Azad GK, Goh V. Cook GJ, et al. Among authors: goh v. J Nucl Med. 2016 Feb;57 Suppl 1:27S-33S. doi: 10.2967/jnumed.115.157867. J Nucl Med. 2016. PMID: 26834098 Free article. Review.

2

Local radiological staging of rectal cancer.

Goh V, Halligan S, Bartram CI. Goh V, et al. Clin Radiol. 2004 Mar;59(3):215-26. doi: 10.1016/j.crad.2003.08.013. Clin Radiol. 2004. PMID: 15037133 Review.

3

Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology?

Goh V, Ng QS, Miles K. Goh V, et al. Invest Radiol. 2012 Jan;47(1):2-4. doi: 10.1097/RLI.0b013e318229ff3e. Invest Radiol. 2012. PMID: 21808202

4

Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker.

Goh V, Ganeshan B, Nathan P, Juttla JK, Vinayan A, Miles KA. Goh V, et al. Radiology. 2011 Oct;261(1):165-71. doi: 10.1148/radiol.11110264. Epub 2011 Aug 3. Radiology. 2011. PMID: 21813743

5

Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation.

Menezes LJ, Kotze CW, Agu O, Richards T, Brookes J, Goh VJ, Rodriguez-Justo M, Endozo R, Harvey R, Yusuf SW, Ell PJ, Groves AM. Menezes LJ, et al. J Nucl Med. 2011 Nov;52(11):1698-703. doi: 10.2967/jnumed.111.093724. Epub 2011 Oct 11. J Nucl Med. 2011. PMID: 21990578 Free article. Clinical Trial.

6

Functional imaging techniques in hepatocellular carcinoma.

Goh V, Sarker D, Osmany S, Cook GJ. Goh V, et al. Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1070-9. doi: 10.1007/s00259-012-2096-x. Epub 2012 Mar 21. Eur J Nucl Med Mol Imaging. 2012. PMID: 22434049 Review.

7

The flow-metabolic phenotype of primary colorectal cancer: assessment by integrated 18F-FDG PET/perfusion CT with histopathologic correlation.

Goh V, Engledow A, Rodriguez-Justo M, Shastry M, Peck J, Blackman G, Endozo R, Taylor S, Halligan S, Ell P, Groves AM. Goh V, et al. J Nucl Med. 2012 May;53(5):687-92. doi: 10.2967/jnumed.111.098525. Epub 2012 Mar 27. J Nucl Med. 2012. PMID: 22454485 Free article. Clinical Trial.

8

Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis.

Chicklore S, Goh V, Siddique M, Roy A, Marsden PK, Cook GJ. Chicklore S, et al. Among authors: goh v. Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):133-40. doi: 10.1007/s00259-012-2247-0. Epub 2012 Oct 13. Eur J Nucl Med Mol Imaging. 2013. PMID: 23064544 Review.

9

Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?

Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B, Ganeshan B, Miles KA, Cook GJ, Goh V. Davnall F, et al. Among authors: goh v. Insights Imaging. 2012 Dec;3(6):573-89. doi: 10.1007/s13244-012-0196-6. Epub 2012 Oct 24. Insights Imaging. 2012. PMID: 23093486 Free PMC article.

10

Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy?

Cook GJ, Yip C, Siddique M, Goh V, Chicklore S, Roy A, Marsden P, Ahmad S, Landau D. Cook GJ, et al. Among authors: goh v. J Nucl Med. 2013 Jan;54(1):19-26. doi: 10.2967/jnumed.112.107375. Epub 2012 Nov 30. J Nucl Med. 2013. PMID: 23204495 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters